MENU
+Compare
GMED
Stock ticker: NYSE
AS OF
Oct 17 closing price
Price
$59.58
Change
+$1.01 (+1.72%)
Capitalization
8.05B

GMED Globus Medical Forecast, Technical & Fundamental Analysis

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers... Show more

GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GMED with price predictions
Oct 17, 2025

GMED in upward trend: price rose above 50-day moving average on October 17, 2025

GMED moved above its 50-day moving average on October 17, 2025 date and that indicates a change from a downward trend to an upward trend. In of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where GMED's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GMED just turned positive on October 01, 2025. Looking at past instances where GMED's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GMED advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GMED as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for GMED crossed bearishly below the 50-day moving average on October 15, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GMED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GMED broke above its upper Bollinger Band on October 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GMED entered a downward trend on October 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GMED’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.873) is normal, around the industry mean (61.544). P/E Ratio (23.093) is within average values for comparable stocks, (37.720). Projected Growth (PEG Ratio) (1.493) is also within normal values, averaging (1.699). GMED has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (3.142) is also within normal values, averaging (79.813).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GMED is expected to report earnings to fall 9.31% to 77 cents per share on November 06

Globus Medical GMED Stock Earnings Reports
Q3'25
Est.
$0.78
Q2'25
Beat
by $0.10
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.18
The last earnings report on August 07 showed earnings per share of 86 cents, beating the estimate of 75 cents. With 726.63K shares outstanding, the current market capitalization sits at 8.05B.
A.I. Advisor
published General Information

General Information

a manufacturer of spinal implants

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
2560 General Armistead Avenue
Phone
+1 610 930-1800
Employees
5000
Web
https://www.globusmedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRGTX10.470.06
+0.58%
VY® CBRE Global Real Estate S
AWSHX66.820.28
+0.42%
American Funds Washington Mutual A
TRWTX25.670.06
+0.23%
Transamerica International Equity I3
FSRFX105.290.20
+0.19%
Fidelity Select Transportation
CDHIX37.790.03
+0.08%
Calvert International Responsible Idx I

GMED and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with VREX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
+1.72%
VREX - GMED
55%
Loosely correlated
-0.43%
CTKB - GMED
52%
Loosely correlated
-1.74%
CVRX - GMED
51%
Loosely correlated
+4.63%
ITGR - GMED
47%
Loosely correlated
+1.66%
TMCI - GMED
45%
Loosely correlated
+0.94%
More

Groups containing GMED

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
+1.72%
Medical/Nursing Services
industry (219 stocks)
50%
Loosely correlated
-0.92%
Health Services
industry (427 stocks)
-2%
Poorly correlated
-0.87%